Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bruna Maria Malagoli Rocha"'
Autor:
Andrielly Silva Rufino, Bruna Maria Malagoli Rocha, João Pedro Resende Castro, Juliana da Silva Garcia Nascimento, Mariana Bráz da Silva
Publikováno v:
Revista de Enfermagem e Atenção à Saúde. 4:5-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::895aa8e6cb316a39e6a9fa48a27e2119
https://doi.org/10.18554/2317-1154v4n2p5
https://doi.org/10.18554/2317-1154v4n2p5
Autor:
Juliana Silva Garcia Nascimento, Andrielly Silva Rufino, Bruna Maria Malagoli Rocha, João Pedro Resende Castro, Mariana Braz Silva
Publikováno v:
Revista de Enfermagem e Atenção à Saúde. :2-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8543b40d36062ab264e71cfe1faac56
https://doi.org/10.18554/2317-1154v4n2p2
https://doi.org/10.18554/2317-1154v4n2p2
Autor:
Marcelo Corassa, Marcello Ferretti Fanelli, Vanessa da Silva Alves, Alexandre Andre Balieiro Anastacio da Costa, Ludmilla Thomé Domingos Chinen, Glauco Baiocchi, Solange Moraes Sanches, Andrea Paiva Gadelha Guimarães, Bruna Maria Malagoli Rocha
Publikováno v:
Applied Cancer Research, Vol 37, Iss 1, Pp 1-6 (2017)
Background Current methods for follow-up of Ovarian Cancer (OC) are widespread, especially with CA125, which, however, is not a perfect biomarker and thus further investigation for new methods of evaluation are warranted. The feasibility of Circulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aada58cf6924dd00f6614062c6a42eb1
https://doi.org/10.1186/s41241-017-0030-z
https://doi.org/10.1186/s41241-017-0030-z
Autor:
Douglas de Oliveira Silva, Izabela Katiucia Tomaz da Silva, Bruna Maria Malagoli Rocha, Laís Silva Palmieri
Publikováno v:
Revista Família, Ciclos de Vida e Saúde no Contexto Social. 7:503
Na neonatologia, o tema “cuidados paliativos” vem ganhando espaço devido à maior frequência das síndromes incompatíveis com a vida, assim como a ocorrência de anormalidades congênitas. Este estudo tem como objetivo relatar a elaboração d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98ebcce6452eb72c8ec7f53051d2c033
https://doi.org/10.18554/refacs.v7i4.3870
https://doi.org/10.18554/refacs.v7i4.3870
Autor:
Marcilei Eliza Cavicchioli Buim, Aldo Lourenço Abbade Dettino, Emne Ali Abdallah, Jose Luiz Gasparini Junior, Ludmilla Thomé Domingos Chinen, Luciana Menezes Mendonca Ocea, Natalia Breve Mingues, Marcello Ferretti Fanelli, Daniel Vilarim Araujo, Virgilio Souza e Silva, Vanessa da Silva Alves, Bruna Maria Malagoli Rocha, Marcelo Calil Machado Netto, Juliana Valim Romero
Publikováno v:
International Journal of Cancer
Thymidylate synthase (TYMS) is an important enzyme for 5‐fluorouracil (5‐FU) metabolism in metastatic colorectal cancer (mCRC) patients. The search for this enzyme in circulating tumor cells (CTCs) can be a powerful tool to follow‐up cancer pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e74f3fc9b591c58fa536ced96daaac
https://pubmed.ncbi.nlm.nih.gov/25721610
https://pubmed.ncbi.nlm.nih.gov/25721610
Autor:
Ludmilla Thomé Domingos, Chinen, Fernanda Machado, de Carvalho, Bruna Maria Malagoli, Rocha, Caroline Motta, Aguiar, Emne Ali, Abdallah, Daniel, Campanha, Natália Breve, Mingues, Thiago Bueno, de Oliveira, Macello Sampaio, Maciel, Gustavo Marchioro, Cervantes, Aldo L A, Dettino, Fernando Augusto, Soares, Patrizia, Paterlini-Bréchot, Marcello Ferretti, Fanelli
Publikováno v:
Journal of thoracic disease. 5(5)
Circulating tumor cells (CTCs) have been reported to be a relevant prognostic biomarker in metastatic patients. However, their clinical use and impact is still under debate. We have thus comparatively and kinetically assessed two CTC detection method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3cae63eaa007076e41ea5845e7c1587d
https://pubmed.ncbi.nlm.nih.gov/24255771
https://pubmed.ncbi.nlm.nih.gov/24255771
Autor:
Marcelo Calil Machado Netto, Jose Luiz Gasparini Junior, Ludmilla Thomé Domingos Chinen, Bruna Maria Malagoli Rocha, Marcilei E. Buim, Mitzi Brentani, Virgilio Souza e Silva, Natalia Breve Mingues, Juliana Valim Romero, Emne Ali Abdallah, Marcello Ferretti Fanelli
Publikováno v:
Cancer Research. 75:5188-5188
Background: colorectal cancer (CRC) is the third leading cause of cancer death in both men and women in the United States (Siegel et al., 2014). So, it is important to look for novel biomarkers to identify and define the best treatment for patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c49d242b9d2bae417520fb4178d6cb5d
https://doi.org/10.1158/1538-7445.am2015-5188
https://doi.org/10.1158/1538-7445.am2015-5188
Autor:
Natalia Breve Mingues, Marcelo Calil Neto, Juliana R. Romero, Marcilei E. Buim, Bruna Maria Malagoli Rocha, Ludmilla Thomé Domingos Chinen, Jose Luiz Gasparini Junior, Emne Ali Abdallah, Virgilio Souza e Silva, Mitzi Brentani, Marcello Ferretti Fanelli, Fernando Augusto Soares
Publikováno v:
Cancer Research. 74:LB-194
Background: colorectal cancer (CRC) was the third most commonly diagnosed cancer in both men and women in the last three years in the United States (Siegel et al., 2011, 2012, 2013). The first strategy for treatment is complete resection of the lesio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3699032d2a9e68c28d17839cfca2bb8
https://doi.org/10.1158/1538-7445.am2014-lb-194
https://doi.org/10.1158/1538-7445.am2014-lb-194
Autor:
Bruna Maria Malagoli Rocha, Fernanda Navarro Loiola, Juliana Valim Romero, Natalia Breve Mingues, Marcelo Calil Machado Netto, Marcilei E. Buim, Vanessa Alves Silva, Virgilio Souza e Silva, Fernando Augusto Soares, Ludmilla Thomé Domingos Chinen, Emne Ali Abdallah, Marcello Ferretti Fanelli, Jose Luiz Gasparini Junior, Aldo Lourenço Abbade Dettino, Luciana Menezes Mendonca Ocea
Publikováno v:
Journal of Clinical Oncology. 32:e22021-e22021
e22021 Background: Pancreatic cancer has a high mortality rate. Given the aggressiveness of the disease, we still lack molecular markers for predicting prognosis. Circulating tumor cells (CTCs) hav...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95df466adab9b08f5437abc046774675
https://doi.org/10.1200/jco.2014.32.15_suppl.e22021
https://doi.org/10.1200/jco.2014.32.15_suppl.e22021
Autor:
Ludmilla Thomé Domingos Chinen, Tiago Felismino, Marcelo Calil Machado Netto, Marcilei E. Buim, Aldo Lourenço Abbade Dettino, Fernando Augusto Soares, Luciana Menezes Mendonca Ocea, Virgilio Souza e Silva, Bruna Maria Malagoli Rocha, Marcello Ferretti Fanelli, Jose Luiz Gasparini Junior, Juliana Valim Romero, Vanessa Alves Silva, Natalia Breve Mingues, Emne Ali Abdallah
Publikováno v:
Journal of Clinical Oncology. 32:e22016-e22016
e22016 Background: CRC is the third most prevalent cancer worldwide. New prognostic markers are needed to identify patients with worse prognosis and to aid the development of more effective therape...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33268c57a548bbc8cad5a0fcb01a1a67
https://doi.org/10.1200/jco.2014.32.15_suppl.e22016
https://doi.org/10.1200/jco.2014.32.15_suppl.e22016